SYShen-Ping Yu

Shen-Ping Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shen-Ping Yu has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Yan Chen

    Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Yuexiu District, Guangzhou, China

    10 shared publications
  • Yan Chen

    Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    8 shared publications
  • Zi-Qiang Wen

    Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    8 shared publications
  • Bao-Lan Lu

    Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China

    6 shared publications
  • Baolan Lu

    Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    6 shared publications
  • Xinyue Yang

    Department of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    6 shared publications

Latest Publications

  • Open Access

    Baseline MRI-based prognostic stratification in T3 rectal cancer using the DISTANCED structured report

    by Yu-Tao Que, Xue-Han Wu, Zi-Qiang Wen, Xin-Ni Cai, Yi-Yan Liu, Shen-Ping Yu, Bao-Lan Lu, Yan Chen

    Objectives: To investigate the prognostic value of baseline MRI characteristics based on the DISTANCED structured report in patients with MRI-defined T3 (mrT3) rectal cancer. Methods: We retrospectively analyzed 190 patients with mrT3 rectal cancer who received neoadjuvant therapy followed by surgical resection between December 2014 and June 2023, with a median follow-up of 43 months (range: 2–126 months). Baseline MRI features, clinical characteristics, and follow-up data were assessed. The patients were randomly assigned to a training cohort ( n = 133) or a validation cohort ( n = 57) in a 7:3 ratio. Cox regression analyses were performed to identify independent risk factors for disease-free survival (DFS), which were then used to construct a nomogram in the training cohort. The nomogram was independently validated using the validation cohort. Harrell’s concordance index (C-index) and time-independent receiver operating characteristic (ROC) analysis were used to evaluate the model’s discrimination. For patient stratification, the DFS rates of high- and low-risk patients were calculated using the Kaplan-Meier method. Results: Baseline MRI-determined lateral lymph node (mrLLN) metastasis, circumference resection margin (mrCRM) involvement, and tumor deposits (mrTDs) were independent predictors of DFS. The nomogram exhibited good discrimination, with a C-index of 0.805 (95% confidence interval [CI]: 0.713–0.896) in the training cohort and 0.851 (95% CI: 0.743–0.959) in the validation cohort. The model also showed good predictive performance for DFS, with area under the ROC curve (AUC) values of 0.782, 0.764, and 0.814 at the 2-year, 3-year, and 5-year follow-ups, respectively, in the training set, and corresponding values of 0.792, 0.828 and 0.824 in the validation cohort. Our nomogram also divided patients into significantly different high- and low-risk groups. Conclusions: The assessment of mrLLN, mrCRM, and mrTDs should be employed for prognosis prediction in mrT3 rectal cancer to optimize preoperative risk stratification and personalized treatment.

  • Spectral detector CT-derived reconstructions for assessment of extramural venous invasion in rectal cancer

    by Yan Chen, Yu-Tao Que, Da Shi, Yi-Yan Liu, Yu-Ru Ma, Wei-Wei Deng, Shen-Ping Yu, Zi-Qiang Wen


  • Open Access

    Application of diffusion kurtosis imaging in differentiating T0-T1 from T2 rectal tumors

    by Yu-Ru Ma, Zhi-Wen Zhang, Zi-Qiang Wen, Xin-Ni Cai, Xue-Han Wu, Yu-Tao Que, Wen-Jie Fan, Quan-Meng Liu, Yi-Yan Liu, Shen-Ping Yu, et al.

    High-spatial-resolution T2-weighted imaging (HR-T2WI) has been demonstrated to overestimate the staging of early rectal cancer, which could lead to missed opportunities for organ-preserving treatments. This study aimed to investigate the value of diffusion kurtosis imaging (DKI) in distinguishing between T0-T1 and T2 rectal tumors. A total of 138 patients with pathologically confirmed T0-T2 rectal tumors who underwent surgery between 2018 and 2023 were included. The pathological findings on tumor staging obtained from surgical specimens were used as the reference standard. The depth of tumor invasion was assessed using HR-T2WI. Kurtosis and diffusivity from DKI and apparent diffusion coefficient (ADC) from diffusion-weighted imaging were measured for the entire tumor. Diffusion parameters were compared between pT0-T1 and pT2 tumors. Multivariable logistic regression and receiver operating characteristic curve analyses were conducted to evaluate the diagnostic performance of significant individual parameters and their combinations in determining pT0-T1 tumors. Kurtosis was lower in pT0-T1 than in pT2 rectal tumors (0.799 vs. 0.950, P < 0.001), while diffusivity and ADC were higher than those of pT2 rectal cancer (1.732 × 10−3 mm2/s vs. 1.368 × 10−3 mm2/s, P < 0.001; 1.316 × 10−3 mm2/s vs. 1.043 × 10−3 mm2/s, P < 0.001). Diffusivity demonstrated the highest diagnostic efficacy in differentiating pT0-T1 from pT2 rectal tumors, with an AUC of 0.810, which was higher that of HR-T2WI (AUC = 0.752, P < 0.001) and kurtosis (AUC = 0.729, P = 0.007), but showed no difference compared to ADC (AUC = 0.785, P = 0.087). A multivariable logistic regression model incorporating HR-T2WI and diffusivity improved diagnostic performance compared with all other individual parameters, achieving an AUC of 0.885 (all P < 0.05). The combination of HR-T2WI and diffusivity can effectively detect pT0-T1 rectal tumors. HR-T2WI combined with diffusivity derived from DKI may serve as a potential biomarker for early assessment of rectal tumors, offering valuable insights for selecting suitable candidates for organ-preserving surgery.


  • Open Access

    Value of dynamic contrast-enhanced MRI in the diagnosis of acute radiation-induced rectal injury in patients with rectal cancer: A comparison with endoscopy

    by Wen-Jie Fan, Yu-Ru Ma, Quan-Meng Liu, Ning Zhang, Yi-Yan Liu, Zi-Qiang Wen, Bao-Lan Lu, Jian-Peng Yuan, Shen-Ping Yu, Yan Chen


  • Open Access

    Discriminating Tumor Deposits From Metastatic Lymph Nodes in Rectal Cancer: A Pilot Study Utilizing Dynamic Contrast-Enhanced MRI

    by Xue-Han Wu, Yu-Tao Que, Xin-Yue Yang, Zi-Qiang Wen, Yu-Ru Ma, Zhi-Wen Zhang, Quan-Meng Liu, Wen-Jie Fan, Li Ding, Yue-Jiao Lang, et al.

    Wu XH, et al. Korean J Radiol. 2025 Mar;26:e37. https://doi.org/10.3348/kjr.2024.0767


  • Application of T1-mapping combined with high-spatial-resolution T2-weighted imaging in discriminating mucinous from nonmucinous adenocarcinoma in rectal cancer

    by Yi-Yan Liu, Zi-Qiang Wen, Yu-Ru Ma, Xin-Yue Yang, Bao-Lan Lu, Quan-Meng Liu, Wen-Jie Fan, Yun-Zhu Wu, Shen-Ping Yu, Yan Chen

    Purpose The aim of this study was to evaluate the utility of T1-mapping, high-spatial-resolution T2-weighted imaging (HR-T2WI), and their combined model in distinguishing between adenocarcinoma not otherwise specified (AC) and mucinous adenocarcinoma (MC) in rectal cancer. Methods A total of 55 patients with pathologically confirmed AC and 37 patients with MC were included in the study. Two radiologists independently reviewed the HR-T2WI and provided assessments of histopathological type. Additionally, T1 relaxation times were quantified using whole-tumor volume methods both pre-contrast (T1p) and post-contrast administration (T1e). The absolute reduction in T1 value (T1d) and the percentage reduction (T1d%) were calculated. Receiver operating characteristic curve analysis was performed to evaluate diagnostic efficacy. Results HR-T2WI demonstrated a sensitivity, specificity, and accuracy of 81.08%, 94.55%, and 89.13%, respectively, in distinguishing rectal MC. T1p, T1e, and T1d values were significantly higher in the MC group compared to the AC group (P < 0.001, = 0.019, and < 0.001, respectively), while there was no statistically significant difference in T1d% between the two groups. Among these quantitative parameters, T1p showed the highest diagnostic efficiency for identifying MC, with a sensitivity of 59.46%, specificity of 92.73%, and moderate diagnostic accuracy (AUC = 0.819). Combining HR-T2WI with T1p (sensitivity = 86.49%, specificity = 92.73, AUC = 0.927) yielded superior performance over single parameters in distinguishing histopathological subtypes. Conclusion T1p is effective in discriminating between AC and MC in rectal cancer. Importantly, the combined model incorporating HR-T2WI and T1p demonstrated enhanced capability in distinguishing histopathological subtypes of rectal cancer, which benefits individualized treatment.


  • Value of orthogonal axial MR images in preoperative T staging of gastric cancer

    by Quan-Meng Liu, Yan Chen, Wen-Jie Fan, Xue-Han Wu, Zhi-Wen Zhang, Bao-Lan Lu, Yu-Ru Ma, Yi-Yan Liu, Yun-Zhu Wu, Shen-Ping Yu, et al.

    Purpose To assess the value of orthogonal axial images (OAI) of MRI in gastric cancer T staging. Methods This retrospective study enrolled 133 patients (median age, 63 [range, 24–85] years) with gastric adenocarcinoma who underwent both CT and MRI followed by surgery. MRI lacking or incorporating OAI and CT images were evaluated, respectively. Diagnostic performance (accuracy, sensitivity, and specificity) for each T stage, overall diagnostic accuracy and rates of over- and understaging were quantified employing pathological T stage as a reference standard. The McNemar’s test was performed to compare the overall accuracy. Results Among patients with pT1–pT4 disease, MRI with OAI (accuracy: 88.7–94.7%, sensitivity: 66.7–93.0%, specificity: 91.5–100.0%) exhibited superior diagnostic performance compared to MRI without OAI (accuracy: 81.2–88.7%, sensitivity: 46.2–83.1%, specificity: 85.5–99.1%) and CT (accuracy: 88.0–92.5%, sensitivity: 53.3–90.1%, specificity: 88.7–98.1%). The overall accuracy of MRI with OAI was significantly higher (83.5%) than that of MRI without OAI (67.7%) (p < .001). However, there was no significant difference in the overall accuracy of MRI with OAI and CT (78.9%) (p = .35). The over- and understaging rates of MRI with OAI (12.0, 4.5%) were lower than those of MRI without OAI (21.8, 10.5%) and CT (12.8, 8.3%). Conclusion OAI play a pivotal role in the T staging of gastric cancer. MRI incorporating OAI demonstrated commendable performance for gastric cancer T-staging, with a slight tendency toward its superiority over CT.


  • Open Access

    Higher perfusion of rectum carcinoma relative to tumor-free rectal wall: quantification by a new imaging biomarker diffusion-derived vessel density (DDVD)

    by Bao-Lan Lu, Dian-Qi Yao, Yì Xiáng J. Wáng, Zhi-Wen Zhang, Zi-Qiang Wen, Ben-Heng Xiao, Shen-Ping Yu

    Background: Diffusion-derived vessel density (DDVD) is a physiological surrogate of the area of micro-vessels per unit tissue area. DDVD is calculated according to: DDVD(b0b5) = Sb0/ROIarea0 – Sb5/ROIarea5, where Sb0 and Sb5 refer to the tissue signal when b is 0 or 5 s/mm2. This study applied DDVD to assess the perfusion of rectal carcinoma (RC). Methods: MRI was performed with a 3.0-T magnet. Diffusion weighted image with b-values of 0, 5 s/mm2 were acquired in 113 patients with non-mucinous RC and 15 patients with mucinous RC. Diffusion-derived vessel density ratio [DDVDr(b0b5)] was DDVD(b0b5) of RC divided by DDVD(b0b5) of tumor-free rectal wall. Results: The median value of the DDVDr(b0b5) for non-mucinous RCs was 1.430, with the majority of RCs showing a higher DDVD than the adjacent tumor-free wall [i.e., with DDVDr(b0b5) >1]. 90.3% (102/113) of non-mucinous RCs were hypervascular, 1.77% (2/113) were iso-vascular, and 7.96% (9/113) were hypovascular. The median value of the DDVDr(b0b5) for mucinous RCs was 1.660. 73.3% (11/15) of mucinous RCs were hypervascular, and 26.7% (4/15) were hypovascular. A trend (P=0.09) was noted that earlier clinical grades non-mucinous RCs had a higher DDVDr(b0b5) than those of the advanced clinical grades (2.245 for grade 0&I, 1.460 for grade II, 1.430 for grade III, 1.130 for grade IV). A non-significant trend was noted with well and moderately differentiated non-mucinous RCs had a higher DDVDr(b0b5)than that of poorly differentiated non-mucinous RCs (median: 1.460 vs. 1.320). A non-significant trend was noted with MRI-detected extramural vascular invasion (mrEMVI) positive non-mucinous RCs had a higher DDVDr(b0b5) than that of mrEMVI negative non-mucinous RCs (1.630 vs. 1.370). Conclusions: DDVD results in this study approximately agree with contrast agent dynamically enhanced CT literature data.


  • MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy

    by Yu-Tao Que, Yan Chen, Xin-Yue Yang, Yu-Ru Ma, Yi-Yan Liu, Zi-Qiang Wen, Bao-Lan Lu, Xue-Han Wu, Zhi-Wen Zhang, Yun-Zhu Wu, et al.

    Objectives To evaluate the identification of tumor deposits (TDs) and the prognostic significance of an MRI tumor regression grade for TDs in patients with rectal cancer treated with neoadjuvant chemoradiotherapy (nCRT). Methods Ninety-one patients with cT3 or cT4 rectal cancer who underwent surgery following nCRT between August 2014 and June 2020 were retrospectively analyzed. Changes in pre-nCRT MRI-detected TDs (mrTDs) were described as mrTD regression grade. The diagnostic performance of post-nCRT MRI-detected TDs (ymrTDs) was compared with histopathological reference standard. The correlation between ymrTDs, mrTD regression grade, and disease-free survival (DFS) was assessed. Results The sensitivity and specificity of ymrTDs were 88.00% and 89.39%, respectively. The area under the receiver operating characteristic curve was 0.887 (95% confidence interval [CI]: 0.803–0.944). The 3-year DFS of patients with positive ymrTDs was significantly lower than of the negative group (44.83% vs 82.73%, p < 0.001). The 3-year DFS was 33.33% for patients with poor regression of mrTDs following nCRT and 55.56% for those with moderate regression, compared to 69.23% in good responders and 83.97% in patients without mrTDs (p < 0.001). On multivariable Cox regression, mrTD regression grade was the only independent MRI factor associated with DFS (p = 0.042). Conclusions Diagnostic performance of ymrTDs was moderate. The mrTD regression grade was independently correlated with DFS, which may have a prognostic implication for treatment and follow-up. Clinical relevance statement Patients with poor regression of MRI-detected tumor deposits may benefit from more aggressive treatments, such as chemoradiation therapy plus induction or consolidation chemotherapy. Key Points • MRI provides a preoperative and noninvasive way to visualize tumor deposits (TDs) after neoadjuvant chemoradiotherapy (nCRT). • Post-nCRT MRI-detected TDs are a poor prognostic marker in cT3 and cT4 rectal cancer patients. • The regression of MRI-detected TDs after nCRT is associated with an improved disease-free survival.


  • Role of dynamic contrast-enhanced MRI in predicting severe acute radiation-induced rectal injury in patients with rectal cancer

    by Yan Chen, Li Ding, Zhi-Wen Zhang, Xue-Han Wu, Yu-Tao Que, Yu-Ru Ma, Yi-Yan Liu, Zi-Qiang Wen, Xin-Yue Yang, Bao-Lan Lu, et al.

    To explore the potential of dynamic contrast-enhanced MRI (DCE-MRI) quantitative parameters in predicting severe acute radiation-induced rectal injury (RRI) in rectal cancer. This retrospective study enrolled 49 patients with rectal cancer who underwent neoadjuvant chemoradiotherapy and rectal MRI including a DCE-MRI sequence from November 2014 to March 2021. Two radiologists independently measured DCE-MRI quantitative parameters, including the forward volume transfer constant (Ktrans), rate constant (kep), fractional extravascular extracellular space volume (ve), and the thickness of the rectal wall farthest away from the tumor. These parameters were compared between mild and severe acute RRI groups based on histopathological assessment. Receiver operating characteristic curve analysis was performed to analyze statistically significant parameters. Forty-nine patients (mean age, 54 years ± 12 [standard deviation]; 37 men) were enrolled, including 25 patients with severe acute RRI. Ktrans was lower in severe acute RRI group than mild acute RRI group (0.032 min-1 vs 0.054 min-1; p = 0.008), but difference of other parameters (kep, ve and rectal wall thickness) was not significant between these two groups (all p > 0.05). The area under the receiver operating characteristic curve of Ktrans was 0.72 (95% confidence interval: 0.57, 0.84). With a Ktrans cutoff value of 0.047 min-1, the sensitivity and specificity for severe acute RRI prediction were 80% and 54%, respectively. Ktrans demonstrated moderate diagnostic performance in predicting severe acute RRI. Dynamic contrast-enhanced MRI can provide non-invasive and objective evidence for perioperative management and treatment strategies in rectal cancer patients with acute radiation-induced rectal injury. • To our knowledge, this study is the first to evaluate the predictive value of contrast-enhanced MRI (DCE-MRI) quantitative parameters for severe acute radiation-induced rectal injury (RRI) in patients with rectal cancer. • Forward volume transfer constant (Ktrans), derived from DCE-MRI, exhibited moderate diagnostic performance (AUC = 0.72) in predicting severe acute RRI of rectal cancer, with a sensitivity of 80% and specificity of 54%. • DCE-MRI is a promising imaging marker for distinguishing the severity of acute RRI in patients with rectal cancer.